Efficacy and safety of azithromycin infusion in patients with NHCAP categorized as group B according to the JRS Guidelines for the Management of Nursing and Healthcare-Associated Pneumonia in Adults

Efficacy and safety of azithromycin infusion in patients with NHCAP categorized as group B according to the JRS Guidelines for the Management of Nursing and Healthcare-Associated Pneumonia in Adults - Efficacy and safety of azithromycin infusion in patients with NHCAP categorized as group B according to the JRS Guidelines for the Management of Nursing and Healthcare-Associated Pneumonia in Adults

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014677

Enrollment

Registered

2014-08-01

Start date

2014-06-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nursing and Healthcare-Associated Pneumonia

Interventions

intravenous administration of azithromycin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients 20 years of age and older 2. Patients with pneumonia categorized as group B according to the JRS Guidelines for the Management of Nursing and Healthcare-Associated Pneumonia in Adults

Exclusion criteria

Exclusion criteria: 1. Patients receiving other antibiotic treatments with their clinical efficacy 2. Contraindication for azithromycin administration 3. Patients deemed ineligible by the attending physicians for various reasons. 4. Patients with serious heart disorders

Design outcomes

Primary

Measure	Time frame
Efficacy and safety of azithromycin at the end of administration or cessation of azithromycin	—

Countries

Japan

Contacts

Public ContactKei Yamasaki

University of Occupational and Environmental Health, Japan Department of Respiratory Medicine

kkyamsaki1019@yahoo.co.jp093-603-1611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026